MUNICH/MARTINSRIED, GERMANY and EMMETTEN, SWITZERLAND / ACCESSWIRE / November 5, 2018 / Secarna Pharmaceuticals ("Secarna"), a new breed of biopharmaceutical company focusing on the discovery and ...
- MetP Pharma's Nascum(R)-VIREX is evaluated for its potential to prevent virus entry at the mucous membrane of the nose - Nascum(R) attracts and blocks airborne particles such as in industrial dust ...
Research shows modulation of the Hedgehog and androgen signaling pathways to discontinue the vicious circle leading to inflammation in the central nervous system and chronic demyelination Treatment ...
Swiss-based specialist pharma R&D company, MetP Pharma, has been granted a Notice of Allowance from the Unites States Patent and Trademark Office (USPTO) for its patent titled, “Treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results